Rainmed Medical Limited (HKG:2297)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2850
-0.0050 (-1.72%)
At close: Mar 4, 2026
Market Cap399.39M +131.1%
Revenue (ttm)25.60M -53.0%
Net Income-113.98M
EPS-0.10
Shares Out1.40B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume190,000
Average Volume847,700
Open0.2800
Previous Close0.2900
Day's Range0.2750 - 0.2850
52-Week Range0.1280 - 0.5300
Beta0.73
RSI51.79
Earnings DateMar 27, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of ... [Read more]

Sector Healthcare
Founded 2014
Employees 214
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2297
Full Company Profile

Financial Performance

In 2024, Rainmed Medical's revenue was 39.82 million, a decrease of -45.61% compared to the previous year's 73.22 million. Losses were -113.50 million, -2.02% less than in 2023.

Financial numbers in CNY Financial Statements